Bayer Equips Plants for Malaria Drug That Could Help Fight Covid-19 -Handelsblatt
April 02 2020 - 5:08AM
Dow Jones News
--Bayer's Chief Executive Werner Baumann said the pharmaceutical
giant is expanding production capacities for its malaria drug
Resochin after indications that the drug could slow down the spread
of the novel coronavirus and therefore lead to a milder course of
the disease, Handelsblatt reports.
--In an interview with the German business newspaper, Mr.
Baumann said further clinical studies would be necessary to clarify
the risk-benefit ratio of the drug but the company's production
plants in Europe would be adjusted to produce it.
--So far, the drug is manufactured only at one plant in
Pakistan, Handelsblatt reports.
Full story (in German): https://bit.ly/39yPrvK
Write to Barcelona editors at barcelonaeditors@dowjones.com
(END) Dow Jones Newswires
April 02, 2020 04:53 ET (08:53 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Historical Stock Chart
From Sep 2023 to Sep 2024